Methods and reagents for the treatment of diseases and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/56 (2006.01) A61K 31/00 (2006.01) A61K 38/13 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2509526

The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering an SSRI or analog or metabolite thereof and, optionally, a corticosteroid or other compound to the patient. The invention also features a pharmaceutical composition containing an SSRI or analog or metabolite thereof and a corticosteroid or other compound for the treatment or prevention of an immunoinflammatory disorder.

L'invention concerne une méthode de traitement d'un patient diagnostiqué, ou susceptible de développer un trouble immuno-inflammatoire par administration à ce patient d'un SSRI (inhibiteur sélectif de recaptage de la sérotonine) ou d'un analogue, ou d'un métabolite de ce produit, et, éventuellement, d'un corticostéroïde ou d'un autre composé. Elle concerne aussi une composition pharmaceutique contenant un SSRI, ou un analogue, ou un métabolite de ce produit et un corticostéroïde ou un autre composé, destinée au traitement ou à la prévention d'un trouble immuno-inflammatoire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods and reagents for the treatment of diseases and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and reagents for the treatment of diseases and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and reagents for the treatment of diseases and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1460141

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.